Engineering multivalent antibodies to target heregulin-induced HER3 signaling in breast cancer cells

por Kang, Jeffrey C, Poovassery, Jayakumar S, Bansal, Pankaj, You, Sungyong, Manjarres, Isabel M, Ober, Raimund J, Ward, E Sally
Publicado 2014

Engineering a HER2-specific antibody-drug conjugate to increase lysosomal delivery and therapeutic efficacy

por Kang, Jeffrey C., Sun, Wei, Khare, Priyanka, Karimi, Mostafa, Wang, Xiaoli, Shen, Yang, Ober, Raimund J., Ward, E. Sally
Publicado 2019